top of page
>
>
Indication prioritization for platform technology
Client Problems
- Our client, a mid-size biotech company, has a platform technology to cross the blood brain barrier and deliver a novel therapeutic modality
- The client wanted to first identify indications with an unmet need that would benefit from the novel therapeutic modality
- The client then wanted to build a framework for prioritizing indications, and to create a commercialization strategy for each prioritized indication
What We Did
- Developed an indication selection and prioritization scheme for the platform technology
- Prioritized the top 5 indications based on preclinical and clinical feasibility and commercialization potential
- Assessed the clinical trial and competitor landscape for each indication
- Created R&D and commercialization strategies for prioritized indications
Our Results And Insight
- Comprehensive indication selection schema
- Current clinical trial assessment of competitors for top prioritized indication
- Top 5 prioritized indications based on technical feasibility of MOA, unmet needs, competitive landscape
- Overview of R&D and commercialization strategy
See other case studies
Commercial Strategy case studies >
Central Nervous System case studies >
Service Areas Details
Commercial Strategy (Indication Assessment)
Therapeutic Areas Details
Central Nervous System (Alzheimer's)
Featured Consultants
bottom of page